Skip to main content
Top
Metadata
Title
Cancer and Soluble FAS
Authors
S. G. Abbasova
M. M. Vysotskii
L. K. Ovchinnikova
M. N. Obusheva
M. A. Digaeva
T. A. Britvin
K. A. Bahoeva
Z. K. Karabekova
I. A. Kazantzeva
U. R. Mamedov
I. B. Manuchin
M. I. Davidov
Publication date
01-10-2009
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 4/2009
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-010-0784-8

Other articles of this Issue 4/2009

Bulletin of Experimental Biology and Medicine 4/2009 Go to the issue

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Methodological Guidelines for Genetic Safety Testing of Cell Transplants

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Morphological Evaluation of Cytoarchitectonics of Aortic Graft at the Biotechnological Stage with Analysis of Changes in Laser-Induced Fluorescence Spectra

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine